header background-block header background-block header background-block header background-block

Find your product


filler image

Logos Biosystems

Logos Biosystems is celebrating its 15th anniversary during the Golden Opportunity Giveaway

Your Golden Opportunity Awaits!

Join Logos Biosystems celebrating its 15th anniversary.

Register for your chance to win one of 15 prizes to celebrate the 15th Anniversary!

Register now
filler image

Vizgen Inc.

Vizgen Wins 2022 BioTech Breakthrough Award!

Vizgen Wins “Overall BioTech Company of the Year” in 2022 BioTech Breakthrough Awards Program

CAMBRIDGE, Mass., November 3, 2022 – Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced it has been named “Overall BioTech Company of the Year” in the second annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe.

Bucher Biotec is very proud to exclusive represent Vizgen in the Swiss market. Contact us in order to explore new dimensions with MERSCOPE™, the first high multiplexing, high resolution in situ platform to combine single-cell and spatial genomics analysis powered by MERFISH technology.

Read the full Press Release
filler image

NanoView Biosciences

Unchained Labs revs up its gene therapy engine, acquires NanoView Biosciences!

Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, acquired NanoView Biosciences. NanoView’s ExoView technology sits in pole position for characterizing exosomes and their recently launched LentiView platform is a game-changer for gene therapy researchers working with lentivirus.

Read the full Press Release
filler image

Bucher Biotec AG

New Representation: Vizgen, Inc.

MERSCOPE™ – A Complete Spatial Genomics Solution

Bucher Biotec is very proud to announce the exclusive distribution agreement with Vizgen for the Swiss market. Explore new dimensions with MERSCOPE™, the first high multiplexing, high resolution in situ platform to combine single-cell and spatial genomics analysis powered by MERFISH technology.

Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single cell spatial genomics, setting the standard for the spatial genomics field. These tools are enabling researchers to gain new insight into the biological systems that govern human health and disease with spatial context.

Learn how Vizgen can accelerate your research
filler image

Bucher Biotec AG

Essential Tools for Life Science R & D

Check out this concise, comprehensive and stimulating Pocket Guide, a SPECTRUM of essential tools which may facilitate your research projects, saving time and money.

Request your personal printed copy!

Alternatively you can view it online or download the pdf

filler image

Mission Bio Tapestri® Update

Mission Bio's New Single-Cell Research Platform Marries Sequencing, Cell Surface Protein Analysis

With the launch this week of its new Tapestri platform, single-cell omics firm Mission Bio is looking to make further inroads into the clinical trial and drug development businesses.

The new system adds protein measurements to the company's traditional focus on single-cell DNA sequencing, allowing researchers to make DNA and protein measurements in a single experiment and in single cells.

The system uses BioLegend's TotalSeq antibodies, which are conjugated to oligonucleotides, allowing them to be read out via single-cell sequencing. The current version of the Tapestri platform is intended for analysis of cell surface proteins, which enables researchers to identify cell type and subtype, generating data analogous to that provided by flow cytometry.

Read the full Press Release
filler image

Logos Biosystems

LUNA™ Family Awarded Platinum Seal of Quality

The LUNA™ family of automated cell counters from Logos Biosystems, part of Aligned Genetics, Inc., has been awarded a Platinum Seal of Quality in recognition of outstanding feedback received from scientists globally.
Seals of Quality recognize the top 0.1% of products that consistently receive the highest customer review ratings on leading laboratory technology website, SelectScience®, and are designed to help scientists worldwide see at a glance the instruments and services their peers love the most.
Among the latest winners is the LUNA™ Family of Automated Cell Counters, by Logos Biosystems, which has now received well over 200 reviews from scientists around the world at an outstanding average overall rating of 4.8 out of 5 stars.
There are four levels of Seal of Quality — Platinum, Gold, Silver and Bronze — and the LUNA™ series becomes one of just 6 winners of the Platinum Seal of Quality since the awards were launched in 2017.
SelectScience Editor-in-Chief and Publisher, Kerry Parker, said: “I would like to take this opportunity to thank all our reviewers around the world for sharing their valuable opinions and also to congratulate Logos Biosystems, who have been recognized by the people who matter most, their customers.”

Read More

Press Releases

Mission Bio Tapestri Product Update

Industry-First Single-cell Multi-omics Capabilities to Simultaneously Detect DNA and Protein from the Same Cell

6. November 2019: Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced its expansion into single-cell multi-omics. The company’s proprietary technology, the Tapestri Platform, is now the first-ever single-cell multi-omic platform capable of detecting DNA and protein changes simultaneously from the same cell — a capability necessary for the development of impactful precision therapies. The company has partnered with BioLegend, a global leader in protein antibody and reagent‎ manufacturing, to co-develop the first commercial solution for combined DNA and protein analysis at the single-cell level.

Bucher Biotec Update: Latest Issues